A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
Louise M AndrewsDennis A HesselinkTeun van GelderBirgit C P KochElisabeth A M CornelissenRoger J M BrüggemannRon H N van SchaikSaskia N de WildtKarlien CransbergBrenda C M de WinterPublished in: Clinical pharmacokinetics (2019)
During the first 6 weeks after transplantation, the tacrolimus weight-normalized starting dose should be higher in pediatric kidney transplant recipients with a lower bodyweight, those who express the cytochrome P450 3A5 genotype, and those who receive a kidney from a deceased donor.